Alpha-1 Foundation
Historical collection: May 2019 · Rating details mostly from 2017. Source & context
What this organization describes
Giving hope to people living with Alpha-1 around the world
Mission and tagline reproduced from the source record.
Three perspectives. One record.
out of 100
out of 100
out of 100
These are the dataset’s historical numeric fields, not a current rating or a new DonorAPI.com assessment. Read the score context ↗
Revenue, expenses, and composition
Program expenses
$8,069,731.20 recorded amountFundraising expenses
$800,142.63 recorded amountAdministrative expenses
$868,447.49 recorded amount- Fundraising efficiency
- $0.08 spent per $1 raised in donations, as defined in the source.
Expense shares are displayed as percentages. Component amounts in this collection match total expenses multiplied by the source ratios; rounding can leave a small difference from the total. The source does not supply a row-specific fiscal year. Field definitions ↗
The leadership information supplied
- Recorded leader
- Henry R. Moehring
- Recorded compensation
- $201,657.00
- Recorded compensation percentage
- 2.06%
These fields do not establish the current officeholder or current compensation. The metadata does not specify the denominator of the leader compensation percentage. Read with context ↗
Inspect all 23 original source fields
Exact source strings are retained below, including numeric precision. A blank value is marked as not reported; zero remains zero.
| Source field | Original source value |
|---|---|
ascoreAccountability & transparency score | 96.0 |
categoryCategory | Health |
descriptionMission & description | The Alpha-1 Foundation is committed to finding a cure for Alpha-1 Antitrypsin Deficiency and to improving the lives of people affected by Alpha-1 worldwide. Alpha-1 Antitrypsin (Alpha-1) Deficiency is a hereditary condition which may result in serious lung disease in adults and/or liver disease in infants, children and adults. The Foundation has realized continuous growth since its inception in 1995 and has developed a solid infrastructure to promote research and the development of new therapies for improving the quality of life for those diagnosed with Alpha-1. The Foundation has invested more than $71 million to support Alpha-1 Antitrypsin research and programs in 112 institutions in North America, Europe, the Middle East and Australia. |
einEIN | 65-0585415 |
tot_expTotal expenses | 9757837.0 |
admin_exp_pAdministrative expense fraction | 0.08900000000000001 |
fund_effFundraising efficiency ($ per $1 raised) | 0.08 |
fund_exp_pFundraising expense fraction | 0.08199999999999999 |
program_exp_pProgram expense fraction | 0.8270000000000001 |
fscoreFinancial score | 99.34 |
leaderRecorded leader | Henry R. Moehring |
leader_compRecorded leader compensation | 201657.0 |
leader_comp_pRecorded leader compensation fraction | 0.0206 |
mottoTagline | Giving hope to people living with Alpha-1 around the world |
nameCharity name | Alpha-1 Foundation |
tot_revTotal revenue | 10833144.0 |
scoreOverall score | 97.13 |
stateState code | FL |
subcategorySubcategory | Diseases, Disorders, and Disciplines |
sizeSource size label | mid |
program_expProgram expenses | 8069731.199000001 |
fund_expFundraising expenses | 800142.6339999998 |
admin_expAdministrative expenses | 868447.4930000001 |
Source: Charity Navigator Scores Expenses Dataset, version 1, attributed to katyjqian on Kaggle. Collection: May 2019; rating details mostly from 2017. Read attribution, scope, and reuse notes.